PROTECTIVE EFFECTS OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR-ALPHA AND INTERFERON-GAMMA AGAINST SURGICALLY SIMULATED WOUND-INFECTION IN MICE

被引：20
|
作者：
HERSHMAN, MJ
PIETSCH, JD
TRACHTENBERG, L
MOONEY, THR
SHIELDS, RE
SONNENFELD, G
机构：
[1] UNIV LOUISVILLE,SCH MED,DEPT MICROBIOL & IMMUNOL,LOUISVILLE,KY 40292
[2] UNIV LOUISVILLE,SCH MED,DEPT ORAL HLTH,LOUISVILLE,KY 40292
[3] UNIV LOUISVILLE,SCH DENT,LOUISVILLE,KY 40292
[4] UNIV LOUISVILLE,PRICE INST SURG RES,DEPT SURG,LOUISVILLE,KY 40292
来源：
BRITISH JOURNAL OF SURGERY | 1989年 / 76卷 / 12期
关键词：
D O I：
10.1002/bjs.1800761220
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1282 / 1286
页数：5
相关论文
共 50 条
  • [31] DIVERGENT EFFECTS OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR-ALPHA ON CELL-GROWTH INVITRO
    SHEPARD, HM
    AGGARWAL, BB
    HASS, PE
    FIGARI, IS
    PALLADINO, MA
    SUGARMAN, BJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 171 - 171
  • [32] Effects of recombinant rat tumor necrosis factor-alpha and interferon-gamma on the respiratory burst of rat polymorphonuclear leukocytes in whole blood
    Vondracek, J
    FOLIA BIOLOGICA, 1997, 43 (03) : 115 - 121
  • [33] TREATMENT OF CANCER-PATIENTS WITH RECOMBINANT INTERFERON-GAMMA INDUCES RELEASE OF ENDOGENOUS TUMOR NECROSIS FACTOR-ALPHA
    AULITZKY, WE
    AULITZKY, WK
    FRICK, J
    HEROLD, M
    GASTL, G
    TILG, H
    BERGER, M
    HUBER, C
    IMMUNOBIOLOGY, 1990, 180 (4-5) : 385 - 394
  • [34] Synergistic inhibition of human chondrocyte proteoglycan genes transcription by interferon-gamma and tumor necrosis factor-alpha
    Diaz, A
    SanzRodriguez, C
    Reginato, AM
    Dodge, GR
    Jimenez, SA
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1475 - 1475
  • [35] SUPPRESSIVE BIOLOGICAL-ACTIVITY OF A SYNTHETIC PENTAPEPTIDE ON HIGHLY ENRICHED HUMAN AND MURINE MARROW HEMATOPOIETIC PROGENITORS - SYNERGISM WITH RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR-ALPHA AND INTERFERON-GAMMA
    LU, L
    FOA, P
    CHILLEMI, F
    SHEN, RN
    LIN, ZH
    CAROW, C
    BROXMEYER, HE
    EXPERIMENTAL HEMATOLOGY, 1989, 17 (09) : 935 - 941
  • [36] Augmented procoagulant activity in cancer patients, treated with recombinant interferon-gamma in addition to recombinant tumor necrosis factor-alpha and melphalan
    Mulder, AB
    Zwaveling, JH
    Smid, WM
    Maring, JK
    vanGinkel, RJ
    Girbes, ARJ
    Koops, HS
    vanderMeer, J
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (06) : 897 - 901
  • [37] A PHASE-I TRIAL OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR AND INTERFERON-GAMMA - EFFECTS OF COMBINATION CYTOKINE ADMINISTRATION INVIVO
    DEMETRI, GD
    SPRIGGS, DR
    SHERMAN, ML
    ARTHUR, KA
    IMAMURA, K
    KUFE, DW
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) : 1545 - 1553
  • [38] INVITRO ANTI-HUMAN IMMUNODEFICIENCY VIRUS ACTIVITIES OF TUMOR NECROSIS FACTOR-ALPHA AND INTERFERON-GAMMA
    WONG, GHW
    KROWKA, JF
    STITES, DP
    GOEDDEL, DV
    JOURNAL OF IMMUNOLOGY, 1988, 140 (01): : 120 - 124
  • [39] Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages
    Malaguarnera, L
    Musumeci, M
    Di Rosa, M
    Scuto, A
    Musumeci, S
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2005, 19 (03) : 128 - 132
  • [40] PHASE-I STUDY OF A COMBINATION OF RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA AND RECOMBINANT INTERFERON-GAMMA IN CANCER-PATIENTS
    KURZROCK, R
    FEINBERG, B
    TALPAZ, M
    SAKS, S
    GUTTERMAN, JU
    JOURNAL OF INTERFERON RESEARCH, 1989, 9 (04): : 435 - 444
12345